Long-term follow-up of Langerhans cell histiocytosis: 39 Years' experience at a single centre

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 8, 2005, Pages 1073-1084

  Bernstrand, Cecilia ^a   Sandstedt, Bengt ^b   Åhström, Lars ^a   Henter, Jan Inge ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

Follow up; Langerhans cell histiocytosis; Mortality; Sequelae

Indexed keywords

ALPHA INTERFERON; CHLORAMBUCIL; CHLORMETHINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PROCARBAZINE; VINBLASTINE;

DIABETES INSIPIDUS; DISEASE COURSE; FOLLOW UP; HIGH SCHOOL; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LONG TERM CARE; LUNG DISEASE; MORTALITY; PHYSICAL EXAMINATION; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SURVIVAL; TIME;

AGE FACTORS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; MALE; PROBABILITY; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; SWEDEN; TIME FACTORS;

EID: 23844490896     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1080/08035250510028263     Document Type: Review

References (30)

1. Arceci RJ. The histiocytoses: the fall of the tower of Babel. Eur J Cancer 1999;35:747-67.
2. Egeler RM, D'Angio GJ. Langerhans' cell histiocytosis. J Pediatr 1995;127:1-11.
3. Carstensen H, Ornvold K. The epidemiology of Langerhans cell histiocytosis in children in Denmark, 1975-1989. Med Pediatr Oncol 1993;21:387-8 (abstract).
4. Karis J, Bernstrand C, Fadeel B, Henter J-I. The incidence of Langerhans cell histiocytosis in children in Stockholm County, Sweden 1992-2001. Pediatr Blood Cancer 2004;43:195 (abstract).
5. Chu T, D 'Angio GJ, Favara B, Ladisch S, Nesbit M, Pritchard J for the Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet 1987;1:208-9.
6. Nezelof C, Basset F, Rousseau MF. Histiocytosis X: Histogenic arguments for a Langerhans' cell origin. Biomedicine 1973;18:365-71.
7. Favara BE, Feller AC, Pauli M, Jaffe ES, Wiess LM, Arico M, et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol 1997;29:157-66.
8. Lahey E. Histiocytosis X: An analysis of prognostic factors. J Pediatr 1975;87:184-9.
9. Komp DM. Long-term sequelae of histiocytosis X. Am J Fed Hem Oncol 1981;3:165-8.
10. Willis B, Ablin A, Weinberg V, Zoger S, Wara WM, Matthay KK. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol 1996;14:2073-82.
11. Haupt R, Nanduri V, Calevo MG, Bernstrand C, Braier JL, Broadbent V, et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 2004;42:438-44.
12. Bernstrand C, Cederlund K, Sandstedt B, Åhström L, Lundell M, Dahlqvist G, et al. Pulmonary findings at long-term follow-up of patients with Langerhans cell histiocytosis. Med Pediatr Oncol 2001;36:459-68.
13. Gustafsson G, Schmigelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia 2000;14:2267-75.
14. Gadner H, Heitger A, Grois N, Gatterer-Menz IG, Ladisch S. Treatment strategy for disseminated Langerhans' cell histiocytosis. Med Pediatr Oncol 1994;23:72-80.
15. Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001;138:728-34.
16. Dunger BD, Broadbent V, Yeoman E, Seckl JR, Lightman SL, Grant DB, et al. The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis. N Engl J Med 1989;321:1157-62.
17. Grois N, Flucher-Wolfram B, Heitger A, Mostbeck GH, Hofmann J, Gadner H. Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study. Med Pediatr Oncol 1995;24:248-56.
18. Nanduri VR, Bareille P, Pritchard J, Stanhope R. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol 2000;53:509-15.
19. Donadieu J, Rolon MA, Thomas C, Brugieres L, Plantaz D, Francois Emile J, et al. Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. J Pediatr 2004;144:344-50.
20. Grois N, Favara BE, Mostbeck GH, Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:287-305.
21. Nanduri VR, Lillywhite L, Chapman C, Parry L, Pritchard J, Vargha-Khadem F. Cognitive outcome of long-term survivors of multisystem Langerhans cell histiocytosis: a single-institution, cross-sectional study. J Clin Oncol 2003;21:2961-7.
22. Grois N, Prayer D, Prosch H, Minkov M, Potschger U, Gadner H. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis. Pediatr Blood Cancer 2004;43:59-65.
23. Calming U, Bernstrand C, Mosskin M, Stone Blander S, Ingvar M, Renter J-I. Brain 18-FDG PET scan in central nervous system Langerhans cell histiocytosis. J Pediatr 2002;141:435-40.
24. Bernstrand B, Cederlund K, Åhström L, Henter J-I. Smoking preceded pulmonary manifestations in two adults with Langerhans cell histiocytosis diagnosed in childhood. Acta Paediatr Scand 2000;89:1389-92.
25. Braier J, Chantada G, Rosso D, Bernaldez P, Amaral D, Latella A, et al. Langerhans cell histiocytosis: Retrospective evaluation of 123 patients at a single institution. Pediatr Hematol Oncol 1999;16:377-85.
26. Titgemeyer C, Grois N, Minkov M, Flucher-Wolfram B, Gatterer-Menz I, Gadner H. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-Study. Med Pediatr Oncol 2001;37:108-14.
27. Henter J-I, Karlén J, Calming U, Bernstrand C, Andersson U, Fadeel B. Successful treatment of Langerhans-cell histiocytosis with etanercept. N Engl J Med 2001;345:1577-8.
28. Fadeel B, Henter J-I. Langerhans cell histiocytosis: neoplasia or unbridled inflammation? Trends Immunol 2003;24:409-10.
29. Calming U, Jacobsson H, Henter J-I. Detection of Langerhans cell histiocytosis with somatostatin analogue scintigraphy: a preliminary report. Med Pediatr Oncol 2000;35:462-7.
30. Calming U, Henter J-I. Elevated ESR and thrombocytosis may be valuable markers of active disease in Langerhans cell histiocytosis. Acta Paediatr 1998;87:1085-7.